Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Premature or Thrombosis
and you are
under 1
years old
This is an observational trial.
You are contributing to medical knowledge about your condition.
Show me locations

The purpose

There are several factor that can be related to Neonatal Thrombotic events. Among them hypercoagulability can be the cause of those events. Factor V Leiden (FVL) and Prothrombin mutation are the most common causes of hereditary thrombophilia. The incidence of in the arab population is known to be higher than the incidence in another western populations. The purpose of this study is to review retrospectively the thrombophilic risk factors that were found in a cohort of premature babies and term newborns treated and investigated at the Neonatal Intensive Care Unit and at the Pediatric Hematology Unit.

Provided treatments

  • Other: Medical Records study
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01443273. The sponsor of the trial is HaEmek Medical Center, Israel and it is looking for 50 volunteers for the current phase.
Official trial title:
Thrombophilic Risk Factors in Preterm and Infants Treated at Ha'Emek Medical Center Between the Years 1990 to 2010